Relationship and associated mechanism of serum fibroblast growth factor 21 and sarcopenia in hemodialysis patients

被引：0
|
作者：
李旻 [1 ]
机构：
[1] Dept Nephrol,3rd Affil Hosp,Soochow Univ
来源：
China Medical Abstracts (Internal Medicine) | 2023年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R692.5 [肾功能衰竭];
学科分类号：
1002 ; 100210 ;
摘要：
Objective To investigate the relationship between serum fibroblast growth factor 21(FGF21) and sarcopenia in hemodialysis(HD) patients,and to explore the relationship between FGF21 and signal pathways related to skeletal muscle metabolism in uremic state at the cellular level.
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
    Chiu, Liang-Te
    Hung, Chi-Di
    Lin, Lin
    Lin, Yu-Li
    Hsu, Bang-Gee
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2022, 2022
  • [2] RELATIONSHIP BETWEEN SERUM FIBROBLAST GROWTH FACTOR 21 LEVELS AND ARTERIOSCLEROSIS FACTORS IN CHRONIC HEMODIALYSIS PATIENTS
    Ogawa, Tetsuya
    Hosoda, Yumi
    Shimada, Miki
    Nishizawa, Yoko
    Shino, Midori
    Shimizu, Himiko
    Inoue, Tomoko
    Yamashita, Tetsuri
    Kyono, Ai
    Higuchi, Chieko
    Omae, Kiyotsugu
    Sakura, Hiroshi
    Nitta, Kosaku
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 652 - 652
  • [3] SERUM FIBROBLAST GROWTH FACTOR 21 LEVELS ARE POSITIVELY ASSOCIATED WITH SKELETAL MUSCLE INDEX IN CHRONIC HEMODIALYSIS PATIENTS
    Chiu, Liang-Te
    Lin, Lin
    Tang, Chi-Chong
    Hsu, Bang-Gee
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 295 - 295
  • [4] Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients
    Wu, Yin-Ting
    Hsu, Bang-Gee
    Wang, Chih-Hsien
    Lin, Yu-Li
    Lai, Yu-Hsien
    Kuo, Chiu-Huang
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (06)
  • [5] Fibroblast growth factor 21 and protein energy wasting in hemodialysis patients
    Post, Adrian
    Groothof, Dion
    Schutten, Joelle C.
    Kelly, Dylan
    Swarte, J. Casper
    Flores-Guerrero, Jose L.
    van der Veen, Yvonne
    Kema, Ido P.
    Ozyilmaz, Akin
    Enya, Ayano
    Westerhuis, Ralf
    Bakker, Stephan J. L.
    Franssen, Casper F. M.
    [J]. CLINICAL NUTRITION, 2021, 40 (06) : 4216 - 4224
  • [6] Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
    Honda, Hirokazu
    Tanaka, Kenji
    Michihata, Tetsuo
    Shibagaki, Keigo
    Yuza, Toshitaka
    Hirao, Keiichi
    Tomosugi, Naohisa
    Ganz, Tomas
    Higashimoto, Yuichiro
    [J]. CLINICAL KIDNEY JOURNAL, 2021, 14 (03) : 943 - 949
  • [7] Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
    Yaghoobi, Gholamhosein
    Shokoohi-Rad, Saeed
    Jafarzadeh, Hamid
    Abdollahi, Elham
    [J]. JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2020, 15 (01) : 38 - 44
  • [8] Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
    Sugimoto, Himiko
    Ogawa, Tetsuya
    Iwabuchi, Yuko
    Otsuka, Kuniaki
    Nitta, Kosaku
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (01) : 99 - 106
  • [9] Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
    Himiko Sugimoto
    Tetsuya Ogawa
    Yuko Iwabuchi
    Kuniaki Otsuka
    Kosaku Nitta
    [J]. International Urology and Nephrology, 2014, 46 : 99 - 106
  • [10] Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients
    Chiu, Liang-Te
    Wang, Chih-Hsien
    Lin, Yu-Li
    Hsu, Bang-Gee
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (12) : 2481 - 2489
12345